Organizational-level predictors of adoption across time: Naltrexone in private substance-use disorders treatment centers

Journal of Studies on Alcohol and Drugs

Volumn 68, Issue 6, 2007, Pages 852-861

  Oser, Carrie B ^a   Roman, Paul M ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NALTREXONE;

ARTICLE; CHI SQUARE TEST; CONTROLLED STUDY; DRUG EFFECT; DRUG MARKETING; HEALTH CARE ORGANIZATION; HEALTH HAZARD; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; PREDICTOR VARIABLE; PRESCRIPTION; SUBSTANCE ABUSE;

EID: 36349001672     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2007.68.852     Document Type: Article

References (52)

1. AIKEN, M., BACHARACH, S.B., AND FRENCH, L.J. Organizational structure, work process, and proposal making in administrative bureaucracies. Acad. Manag. J. 23: 631-652, 1980.
2. ALCOHOLICS ANONYMOUS. The AA Member, Medication, and Other Drugs, New York: Alcoholics Anonymous World Services, 1984.
3. ALLISON, P.D. Survival Analysis Using the SAS System: A Practical Guide, Cary, NC: SAS Institute, 1995.
4. BACKER, T.E., DAVID, S.L., AND SOUCY, G. Reviewing the Behavioral Science Knowledge Base on Technology Transfer, NIDA Research Monograph No. 155, NIH Publication No. 95-4035, Bethesda, MD: National Institute on Drug Abuse, 1995.
5. BAILYN, L. Autonomy in the industrial R&D lab. Human Resource Manag. 24: 129-146, 1985.
6. BERWICK, D.M. Disseminating innovations in health care. JAMA 289: 1969-1975, 2003.
7. CASTLE, N.G. AND BANASZAK-HOLL, J. Top management team characteristics and innovation in nursing homes. Gerontologist 37: 572-580, 1997.
8. DAMANPOUR, F. Organizational innovation: A meta-analysis of effects of determinants and moderators. Acad. Manag. J. 34: 555-590, 1991.
9. DEWAR, R.D. AND DUTTON, J.E. The adoption of radical and incremental innovations: An empirical analysis. Manag. Sci. 32: 1422-1433, 1986.
10. DIAMOND, M.A. The Unconscious Life of Organizations, Westport, CT: Quorum, 1993.
11. DIAMOND, M.A. Organizational change as human process, not technique. In: BACKER, T.E., DAVID, S.L., AND SOUCY, G. (Eds.) Reviewing the Behavioral Science Knowledge Base on Technology Transfer. NIDA Research Monograph No. 155, NIH Publication No. 95-4035, Bethesda, MD: National Institute on Drug Abuse, 1995, pp. 119-131.
12. DIMAGGIO, P.J. AND POWELL, W.W. The iron cage revisited: Institutional isomorphism and collective rationality in organizational fields. Amer. Sociol. Rev. 48: 147-160, 1983.
13. DRAZIN, R. AND SCHOONHOVEN, C.B. Community, population, and organization effects on innovation: A multilevel perspective. Acad. Manag. J. 39: 1065-1083, 1996.
14. DUCHARME, L.J., KNUDSEN, H.K., AND ROMAN, P.M. Trends in the adoption of medications for alcohol dependence. J. Clin. Psychopharmacol. 26 (Suppl No. 1): S13-S19, 2006.
15. ETTLIE, J.E., BRIDGES, W.P., AND O'KEEFE, R.D. Organizational strategy and structural differences for radical versus incremental innovation. Manag. Sci. 30: 682-695, 1984.
16. FENNELL, M.L. Synergy, influence, and information in the adoption of administrative innovations. Acad. Manag. J. 27: 113-129, 1984.
17. FOREMAN, R.F., BOVASSO, G., AND WOODY, G. Staff beliefs about addiction treatment. J. Subst. Abuse Treat. 21: 1-9, 2001.
18. GLASNER, E.M., ABELSON, H.H., AND GARRISON, K.N. Putting Knowledge to Use: Facilitating the Diffusion of Knowledge and the Implementation of Planned Change, San Francisco, CA: Jossey-Bass, 1983.
19. GLASSMAN, A.M. Rethinking organization stability as a determinant for innovation adoption and diffusion. In: BACKER, T.E., DAVID, S.L., AND SOUCY, G. (Eds.) Reviewing the Behavioral Science Knowledge Base on Technology Transfer. NIDA Research Monograph No. 155, NIH Publication No. 95-4035, Bethesda, MD: National Institute on Drug Abuse, 1995, pp. 132-146.
20. GRIFFITH, J.R., SAHNEY, V.K., AND MOHR, R.A. Re-Engineering Health Care: Building on CQU, Ann Arbor, MI: Health Administration Press, 1995.
21. KAVANAGH, K.H. Collaboration and diversity in technology transfer. In: BACKER, T.E., DAVID, S.L., AND SOUCY, G. (Eds.) Reviewing the Behavioral Science Knowledge Base on Technology Transfer. NIDA Research Monograph No. 155, NIH Publication No. 95-4035, Bethesda, MD: National Institute on Drug Abuse, 1995, pp. 42-64.
22. KIMBERLY, J.R. AND EVANISKO, M.J. Organizational innovation: The influence of individual, organizational, and contextual factors on hospital adoption of technological and administrative innovations. Acad. Manag. J. 24: 689-713, 1981.
23. KNUDSEN, H.K., DUCHARME, L.J., ROMAN, P.M., AND LINK, T. Buprenorphine diffusion: The attitudes of substance abuse treatment counselors. J. Subst. Abuse Treat. 29: 95-106, 2005.
24. LAMB, S., GREENLICK, M.R., AND MCCARTY, D. (Eds.) Bridging the Gap Between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment, Washington, DC: National Academies Press, 1988.
25. LEHMAN, W.E.K., GREENER, J.M., AND SIMPSON, D.D. Assessing organizational readiness for change. J. Subst. Abuse Treat. 22: 197-209, 2002.
26. LEONARD-BARTON, D. AND SINHA, D.K. Developer-user interaction and user satisfaction in internal technology transfer. Acad. Manag. J. 36: 1125-1139, 1993.
27. MCCALLUM, D.B. Risk communication: A tool for behavior change. In: BACKER, T.E., DAVID, S.L., AND SOUCY, G. (Eds.) Reviewing the Behavioral Science Knowledge Base on Technology Transfer. NIDA Research Monograph No. 155, NIH Publication No. 95-4035, Bethesda, MD: National Institute on Drug Abuse, 1995, pp. 65-89.
28. MCGOVERN, M.P., FOX, T.S., XIE, H., AND DRAKE, R.E. A survey of clinical practices and readiness to adopt evidence-based practices: Dissemination research in addiction treatment system. J. Subst. Abuse Treat. 26: 305-312, 2004.
29. MCGRATH, C. AND ZELL, D. The future of innovation diffusion research and its implications for management: A conversation with Everett Rogers. J. Manag. Inquiry 10: 386-391, 2001.
30. MARK, T.L., KRANZLER, H.R., POOLE, V.H., HAGAN, C.A., MCLEOD, C., AND CROSSE, S. Barriers to the use of medications to treat alcoholism. Amer. J. Addict. 12: 281-294, 2003.
31. MEYER, M., JOHNSON, J.D., AND ETHINGTON, C. Contrasting attributes of preventive health innovations. J. Communicat. 47 (2): 112-131, 1997.
32. MILLER, D. AND FRIESEN, P.H. Innovation in conservative and entrepreneurial firms: Two models of strategic momentum. Strat. Manag. J. 3: 1-25, 1982.
33. MOCH, M.K. AND MORSE, E.V. Size, centralization, and organizational adoption of innovations. Amer. Sociol. Rev. 42: 716-725, 1977.
34. NATIONAL TREATMENT CENTER STUDY. Available at: http://www.uga.edu/ntcs/reports/index.htm. Accessed January 6, 2007.
35. O'MALLEY, S.S., JAFFE, A.J., CHANG, G., SCHOTTENFELD, R.S., MEYER, R.E., AND ROUNSAVILLE, B. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Arch. Gen. Psychiat. 49: 881-887, 1992.
36. OSER, C.B., TINDALL, M.S., AND LEUKEFELD, C.G. HIV testing in correctional agencies and community treatment programs: The impact of internal organizational structure. J. Subst. Abuse Treat. 32: 301-310, 2007.
37. PEAY, M.Y. AND PEAY, E.R. Innovation in high risk drug therapy. Social Sci. Med. 39: 39-52, 1994.
38. RAELIN, J.A. The dilemma of autonomy vs. control in the management of organizational professionals (prologue). Human Resource Manag. 24: 123-127, 1985.
39. READ, J.P., KAHLER, C.W., AND STEVENSON, J.F. Bridging the gap between alcoholism treatment research and practice: Identifying what works and why. Prof. Psychiat. Res. Pract. 32: 227-238, 2001.
40. ROGERS, E.M. Diffusion of Innovations, 5th Edition, New York: The Free Press, 2003.
41. ROMAN, P.M. AND JOHNSON, J.A. Adoption and implementation of new technologies in substance abuse treatment. J. Subst. Abuse Treat. 22: 211-218, 2002.
42. ROMAN, P.M., JOHNSON, J.A., AND BLUM, T.C. The transformation of private alcohol problem treatment: Results of a national study. In: LEVY, J.A., STEPHENS, R.C., AND MCBRIDE, D.C. (Eds.) Emergent Issues in the Field of Drug Abuse, Stamford, CT: JAI Press, 2000, pp. 321-342.
43. RYCHTARIK, R.G., CONNORS, G.J., DERMEN, K.H., AND STASIEWICZ, P.R. Alcoholics Anonymous and the use of medications to prevent relapse: An anonymous survey of member attitudes. J. Stud. Alcohol 61: 134-138, 2000.
44. SCOTT, W.R. Institutions and Organizations, Thousand Oaks, CA: Sage, 1995.
45. STACEY, R.D. Managing the Unknowable: Strategic Boundaries between Order and Chaos in Organizations, San Francisco, CA: Jossey-Bass, 1992.
46. TALEFF, M.J. AND SWISHER, J.D. The seven core functions of a master's level alcohol and other drug counselor. J. Alcohol Drug Educ. 42 (3): 1-17, 1997.
47. THOMAS, R.R., JR. Beyond Race and Gender: Unleashing the Power of Your Total Work Force by Managing Diversity, New York: AMACOM, 1991.
48. TORNATZKY, L.G. AND KLEIN, K. Innovation and characteristics of innovation adoption implementation: A meta-analysis of findings. IEEE Transact. Eng. Manag. 29: 28-45, 1982.
49. VOLPICELLI, J.R., ALTERMAN, A.I., HAYASHIDA, M., AND O'BRIEN, C.P. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiat. 49: 876-880, 1992.
50. WEISS, R., CHARNEY, E., BAUMGARDNER, R.A., GERMAN, P.S., MELLITS, E.D., SKINNER, E.A., AND WILLIAMSON, J.W. Changing patient management: What influences the practicing pediatrician. Pediatrics 85: 791-795, 1990.
51. WESTPHAL, J.D., GULATI, R., AND SHORTELL, S.M. Customization or conformity? An institutional and network perspective on the content and consequences of TQM adoption. Admin. Sci. Q. 42: 366-394, 1997.
52. WHITE, W.L. Slaying the Dragon: The History of Addiction Treatment and Recovery in America, Bloomington, IL: Chestnut Health Systems, 1998.